nonoinc.ca
Get leads like Nonoinc — and thousands more
Build targeted lists by tech stack, traffic, and more
NoNO: The Stroke Trial Gamble
A Canadian biotech risks everything on a single peptide for acute ischemic stroke
NoNO Inc. isn't playing games with its name. This Canadian biotech is betting $18.1M in revenue and 117 employees on one mission: rewriting the playbook for treating acute ischemic stroke with their peptide nerinetide. The global Phase 3 ESCAPE-NEXT trial is live, and the stakes couldn't be higher.
"When your entire valuation rests on excluding thrombolysis in stroke care, you're not just challenging the standard—you're betting the company on it."
The Surgical Strike Strategy
NoNO's core insight is brutal in its simplicity: thrombolysis (clot-busting drugs) is the current standard, but it's not always the answer. By focusing exclusively on ESCAPE-NEXT patients excluded from thrombolysis, they're not competing—they're creating a blue ocean in a $4B+ stroke market. It's a high-risk, high-reward move that only a confident management team would attempt.
The Leadership Cadre
CEO Michael Tymianski isn't flying solo. With Corey Adams on business development, Yatika Kohli on compliance, and Kathy Heard running clinical ops, this is a veteran crew that knows how to navigate FDA pathways. The 117-person team is lean for a Phase 3 player—suggesting either extreme efficiency or that they're keeping burn low until the data hits.
The tech stack tells a story of pragmatism over flash. jQuery and Bootstrap (not exactly bleeding edge) paired with Google Analytics and Zendesk suggest a team focused on function over form. This isn't a company wasting money on fancy frontend frameworks when they need every dollar for the trial.
- Revenue: $18.1M (likely from partnerships/grants, not product sales)
- Traffic: 2,083 monthly visits—this is a scientific company, not a consumer play
- Traffic split: 42% direct, 33% organic—shows strong brand recall in the medical community
- Employee efficiency: ~$155K revenue per employee for a pre-revenue biotech is solid
The Verdict: High-Stakes Science or Strategic Masterstroke?
NoNO is playing the long game with nerinetide. If ESCAPE-NEXT hits, they own a stroke niche. If it misses, the 117-person team needs a pivot. For investors: this is a binary outcome play with experienced management and controlled burn. For founders: study their focus—one molecule, one trial, one shot.
What tech stack does Nonoinc use?
How much traffic does Nonoinc get?
Traffic & Engagement
Traffic Sources
Where is Nonoinc's audience located?
What keywords does Nonoinc rank for?
2 keywordsHow is Nonoinc's SEO?
Open Graph Image
https://res.cloudinary.com/boldcloud/images/w_1280,h_883/f_auto,q_auto/v1647963013/NONO_Wall_People-min/NONO_Wall_People-min.jpeg?_i=AA
Meta Tags
NoNO Inc. | Change Everything
NoNO Inc. Announces the Start of the Global Phase 3 ESCAPE-NEXT Trial of the Peptide Nerinetide in Acute Ischemic Stroke Excluding Thrombolysis
Schema Types
What is Nonoinc's revenue?
Who works at Nonoinc?
Loading leads...
What do customers think of Nonoinc?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Nonoinc
What is Nonoinc's Revenue?
What does Nonoinc do?
How fast is Nonoinc growing?
What technologies does Nonoinc use?
Who are Nonoinc's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Nonoinc?
Contact Information
Export nonoinc.ca Data
Download the complete tech stack, analytics, leads, and company data for nonoinc.ca in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About nonoinc.ca
NoNO Inc. Announces the Start of the Global Phase 3 ESCAPE-NEXT Trial of the Peptide Nerinetide in Acute Ischemic Stroke Excluding Thrombolysis
Company Overview
Contact nonoinc.ca
Phone Numbers
Technology Stack
nonoinc.ca uses 15 technologies across their website including Cloudinary, Google Fonts, PHP, and more.
Media
Cloudinary
Fonts
Google Fonts
Programming Languages
PHP
CMS
WordPress
Customer Support
Zendesk
Analytics & Marketing
Google Analytics
Traffic & Audience
nonoinc.ca receives approximately 2.1K monthly visitors and ranks #7,544,015 globally. The website has a bounce rate of 35% with visitors viewing an average of 1.8 pages per visit. Users spend an average of 0:40 on the site.
The majority of nonoinc.ca's traffic comes from .
Frequently Asked Questions
What is nonoinc.ca?
What technologies does nonoinc.ca use?
How popular is nonoinc.ca?
Related Searches
This page provides publicly available information about nonoinc.ca. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit nonoinc.ca directly at https://nonoinc.ca.